Skip to main content

Page of 4
and
  1. Article

    Open Access

    Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas

    Genoty** epidermal growth factor receptor (EGFR) is an essential process to indicate lung adenocarcinoma patients for the most appropriate treatment. Liquid biopsy using circulating tumor DNA (ctDNA) potentiall...

    Daisuke Akahori, Yusuke Inoue, Naoki Inui, Masato Karayama in Scientific Reports (2021)

  2. Article

    Open Access

    Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

    The efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine’s efficacy and safety at a low do...

    Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe in BMC Cancer (2021)

  3. Article

    Open Access

    Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study

    Currently, there are two antifibrotics used to treat idiopathic pulmonary fibrosis (IPF): pirfenidone and nintedanib. Antifibrotics slow disease progression by reducing the annual decline of forced vital capac...

    Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono in BMC Pulmonary Medicine (2021)

  4. No Access

    Article

    Omeprazole suppresses endothelial calcium response and eNOS Ser1177 phosphorylation in porcine aortic endothelial cells

    Although high doses of proton pump inhibitors can elicit an anticancer effect, this strategy may impair vascular biology. In particular, their effects on endothelial Ca2+ signaling and production of endothelium-d...

    Chiaki Kamiya, Keiichi Odagiri, Akio Hakamata, Ryugo Sakurada in Molecular Biology Reports (2021)

  5. Article

    Open Access

    Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis

    The differential diagnosis of interstitial lung diseases (ILDs), particularly idiopathic pulmonary fibrosis (IPF) versus other non-IPF ILDs, is important for selecting the appropriate treatment. This retrospec...

    Yoichiro Aoshima, Yasunori Enomoto, Shigeki Muto, Shiori Meguro, Hideya Kawasaki in Lung (2021)

  6. Article

    Open Access

    Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study

    Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is a major prognostic determinant. However, evidence for its prognostic strength is mainly based on the results of small cohort studies with stati...

    Takahito Suzuki, Hironao Hozumi, Koichi Miyashita, Masato Kono in Scientific Reports (2021)

  7. Article

    Open Access

    Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray

    Detection of idiopathic interstitial pneumonias (IIPs) on chest X-ray is difficult for non-specialist physicians, especially in patients with mild IIPs. The current study aimed to evaluate the usefulness of a ...

    Masato Karayama, Yoichiro Aoshima, Hideki Yasui, Hironao Hozumi in Scientific Reports (2021)

  8. Article

    Open Access

    Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival

    The precise classification of idiopathic interstitial pneumonia (IIP) is essential for selecting treatment as well as estimating clinical outcomes; however, this is sometimes difficult in clinical practice. Th...

    Yoichiro Aoshima, Masato Karayama, Yasuoki Horiike, Kazutaka Mori in BMC Pulmonary Medicine (2021)

  9. No Access

    Article

    Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations

    The efficacy and safety of combination therapy with erlotinib and bevacizumab in elderly patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) gene mutations are unkno...

    Yoichiro Aoshima, Masato Karayama, Naoki Inui, Hideki Yasui in Investigational New Drugs (2021)

  10. Article

    Open Access

    Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease

    Bronchoalveolar lavage (BAL) plays a role in the diagnosis of diffuse parenchymal lung diseases (DPLD); however, poor BAL fluid (BALF) recovery results in low diagnostic reliability. BAL is relatively safe, bu...

    Keigo Koda, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki in Scientific Reports (2021)

  11. Article

    Open Access

    Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

    Cell-free DNA (cfDNA) genoty** in plasma using the cobas EGFR Mutation Test v2 (cobas) is the first liquid biopsy as a companion diagnosis to identify the EGFR T790M mutation (T790M) after the failure of tre...

    Yuko Oya, Tatsuya Yoshida, Kazuhiro Asada, Tetsuya Oguri, Naoki Inui in BMC Cancer (2021)

  12. Article

    Open Access

    Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium

    Viral respiratory tract infections, such as influenza A virus (IAV), are common and life-threatening illnesses worldwide. The mechanisms by which viruses are removed from the respiratory tract are indispensabl...

    Yosuke Kamiya, Tomoyuki Fujisawa, Mineo Katsumata, Hideki Yasui in Respiratory Research (2020)

  13. No Access

    Article

    Clinical Outcomes of Anti-programmed Death-1 Antibody–Related Pneumonitis in Patients with Non-Small Cell Lung Cancer

    Immune checkpoint inhibitors have provided a breakthrough in cancer therapy. Pneumonitis related to immune checkpoint inhibitors is a serious immune-related adverse event that can be fatal. However, the respon...

    Takafumi Koyauchi, Naoki Inui, Masato Karayama in SN Comprehensive Clinical Medicine (2020)

  14. Article

    Open Access

    Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Kazuo Tsuchiya, Yuzo Suzuki, Katsuhiro Yoshimura, Hideki Yasui in Scientific Reports (2020)

  15. Article

    Open Access

    CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes

    Lung fibrosis is a serious life-threatening condition whose manifestation varies according to the localization and characteristics of fibroblasts, which are considered heterogeneous. Therefore, to better under...

    Sayomi Matsushima, Yoichiro Aoshima, Taisuke Akamatsu in BMC Pulmonary Medicine (2020)

  16. Article

    Open Access

    Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

    CD206, a mannose receptor, is mainly expressed on the surface of alternatively activated macrophages where it acts as a pattern recognition receptor and plays a role in innate and adaptive immunity. This study...

    Kazuo Tsuchiya, Yuzo Suzuki, Katsuhiro Yoshimura, Hideki Yasui in Scientific Reports (2019)

  17. Article

    Open Access

    Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis

    Weight loss progresses with the progression of idiopathic pulmonary fibrosis (IPF), and acute exacerbation of IPF (AE-IPF) frequently occurs in its advanced stage. Adiponectin and leptin are adipokines produce...

    Noriyuki Enomoto, Yoshiyuki Oyama, Hideki Yasui, Masato Karayama in Scientific Reports (2019)

  18. No Access

    Article

    Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting

    There remains an unmet clinical need for the control of chemotherapy-induced nausea and vomiting (CINV), particularly in the prevention of nausea and the delayed phase control. We evaluated the efficacy and sa...

    Kazuki Tanaka, Naoki Inui, Masato Karayama in Cancer Chemotherapy and Pharmacology (2019)

  19. No Access

    Article

    Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

    Background Optimal maintenance therapy for lung squamous cell carcinoma (SCC) has not been established. The aim of this study was to evaluate the efficacy and safety of switch maintenance therapy with S-1, an ora...

    Norimichi Akiyama, Masato Karayama, Naoki Inui, Hideki Yasui in Investigational New Drugs (2019)

  20. Article

    Open Access

    Physiological and morphological differences of airways between COPD and asthma–COPD overlap

    Overlap of asthma and COPD has attracted attention recently. We aimed to clarify physiological and morphological differences of the airways between COPD and asthma–COPD overlap (ACO). Respiratory resistance an...

    Masato Karayama, Naoki Inui, Hideki Yasui, Masato Kono in Scientific Reports (2019)

Page of 4